|
No |
Module Name |
Drug Design and Development |
|
1 |
Code of Subjects |
P10A02.0716 |
|
2 |
Study load |
2(2-0) credits Contact hour per semester: 27 Independent study hour per semester : 64 Total workload : 91 |
|
3 |
Semester |
7 |
|
4 |
Precondition |
There is no |
|
5 |
Competence |
At the end of this unit students will have an understanding of: 1. The major approaches to drug discovery; 2. The process of identifying a drug target and the steps required to validate that target; 3. Drugs that treat infectious diseases and approaches to developing those drugs; 4. The importance of pharmaceutics in drug development; 5. Pharmacokinetics in drug development; 6. The clinical trial process; 7. Legal documentation of pharmaceutical product invention |
|
6 |
Elements of Competency |
MKK |
|
7 |
Type Competency |
Main competence |
|
8 |
Syllabus |
This course is aimed at explaining the process by which new drugs are discovered and developed, from initial idea to full clinical use in humans, and to describe the interface between the biosciences and the pharmaceutical business. |
|
9 |
Attribute Soft Skill |
Ethics, awareness, and discipline |
|
10 |
Learning methods |
Presentation, lecturer, discussion, project |
|
11 |
Learning Media |
LCD Projector |
|
12 |
Appraisal |
Examination (60%), Task (25%), and Project-Based Task (15%) |
|
13 |
Lecturer |
Prof. apt. Muchtaridi, Ph.D, Apt, Dr. apt. Sandra Megantara, M.Far, apt. Nasrul Wathoni, Ph.D., and Dr. apt. Ade Zuhrotun, M.Si |
|
14 |
Reference |
|
